MedPath

Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

Not Applicable
Completed
Conditions
Asthma
Chronic Obstructive Pulmonary Disease
Interventions
Device: Diskus inhaler
Device: Easyhaler type A
Device: Easyhaler type B
Registration Number
NCT01424137
Lead Sponsor
Orion Corporation, Orion Pharma
Brief Summary

The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
227
Inclusion Criteria
  • Written informed consent (IC) obtained
  • Documented diagnosis of asthma and/or COPD
  • Age: 4 years and above
Read More
Exclusion Criteria
  • Any severe chronic respiratory disease other than asthma or COPD
  • Acute respiratory infection
  • Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Diskus inhalerDiskus inhaler-
Easyhaler type AEasyhaler type A-
Easyhaler type BEasyhaler type B-
Primary Outcome Measures
NameTimeMethod
Peak inspiratory flow rate through the placebo Easyhaler and Diskus inhalers1 day
Secondary Outcome Measures
NameTimeMethod
The inspiratory volume through the placebo Easyhaler and Diskus inhalers will be measured at the same time with the peak inspiratory flow rate1 day

Trial Locations

Locations (5)

Tartu University Hospital, Lung Clinic

🇪🇪

Tartu, Estonia

Turku University Hospital

🇫🇮

Turku, Finland

Children's Clinic of Tartu, Allergy Centre

🇪🇪

Tartu, Estonia

Jorvi Hospital HUS

🇫🇮

Espoo, Finland

Lasnamäe Medicum

🇪🇪

Tallinn, Estonia

© Copyright 2025. All Rights Reserved by MedPath